IHC was used to stain tumor tissues; however, because of the absence of some samples, ICOS levels were only determined in 47 patients, PD‐L1 levels were only measured in 62 patients, CD163 levels were only determined in 67 patients, and FOXP3 levels were only determined in 66 patients. This evidence concerns the gene CD163 and neoplasm.